adamantane has been researched along with sr141716 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| DiPatrizio, NV; Järbe, TU; Lu, D; Makriyannis, A | 1 |
| Lebovitz, H | 1 |
| Klein, HH; Meier, JJ; Schmidt, WE | 1 |
| Bajaj, S; Bergman, J; Makriyannis, A; Nikas, SP; Paronis, CA; Thakur, GA; Vemuri, VK | 1 |
| Järbe, TU; LeMay, BJ; Makriyannis, A; Thakur, GA | 1 |
| Cheng, X; Guddat, LW; Jiang, B; Jiang, H; Li, J; Liu, Z; Rao, Z; Wu, L; Yang, H; Yang, X; Yang, Y; Zhang, B; Zhang, J; Zhang, L; Zhao, Y | 1 |
| Bush, JM; Cabanlong, CV; Fantegrossi, WE; Fujiwara, R; Fukuda, S; Gogoi, J; Jackson, BK; McCain, K; Pinson, A; Prather, PL; Radominska-Pandya, A; Shoeib, A; Yarbrough, AL | 1 |
2 review(s) available for adamantane and sr141716
| Article | Year |
|---|---|
Diabetes: assessing the pipeline.
Topics: Adamantane; Alkanesulfonates; Amyloid; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Exenatide; Glycine; Humans; Hypoglycemic Agents; Indoles; Islet Amyloid Polypeptide; Maleimides; Nitriles; Oxazoles; Peptides; Phenylpropionates; Piperidines; PPAR alpha; PPAR gamma; Protein Kinase C; Pyrazoles; Pyrrolidines; Receptor, Cannabinoid, CB1; Receptors, Glucagon; Rimonabant; Venoms; Vildagliptin | 2006 |
[New concepts in the treatment of type 2 diabetes].
Topics: Adamantane; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Liraglutide; Nitriles; Peptides; Piperidines; Pyrazines; Pyrazoles; Pyrrolidines; Rimonabant; Sitagliptin Phosphate; Triazoles; Venoms; Vildagliptin | 2007 |
5 other study(ies) available for adamantane and sr141716
| Article | Year |
|---|---|
(-)-Adamantyl-delta8-tetrahydrocannabinol (AM-411), a selective cannabinoid CB1 receptor agonist: effects on open-field behaviors and antagonism by SR-141716 in rats.
Topics: Adamantane; Animals; Cannabinoid Receptor Antagonists; Cannabinoids; Dronabinol; Drug Interactions; Exploratory Behavior; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant | 2004 |
Diuretic effects of cannabinoids.
Topics: Adamantane; Animals; Arachidonic Acids; Benzoxazines; Body Temperature; Cannabinoid Receptor Antagonists; Cannabinoids; Cannabinol; Confidence Intervals; Diuresis; Diuretics; Dose-Response Relationship, Drug; Dronabinol; Female; Male; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Water | 2013 |
A high efficacy cannabinergic ligand (AM4054) used as a discriminative stimulus: Generalization to other adamantyl analogs and Δ(9)-THC in rats.
Topics: Adamantane; Animals; Cannabinol; Discrimination Learning; Dronabinol; Generalization, Psychological; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant | 2016 |
Crystal Structures of Membrane Transporter MmpL3, an Anti-TB Drug Target.
Topics: Adamantane; Antitubercular Agents; Bacterial Proteins; Biological Transport; Drug Delivery Systems; Drug Design; Ethylenediamines; Humans; Membrane Proteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenylurea Compounds; Rimonabant; Tuberculosis | 2019 |
Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity.
Topics: Adamantane; Animals; Cannabinoid Receptor Antagonists; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Female; Humans; Indazoles; Male; Mice; Mice, Inbred C57BL; Microsomes, Liver; Oxidation-Reduction; Polymorphism, Genetic; Protein Binding; Receptor, Cannabinoid, CB1; Recombinant Proteins; Rimonabant; Sex Factors | 2020 |